Literature DB >> 10859146

The effect of rate of drug administration on the extent and time course of phencyclidine distribution in rat brain, testis, and serum.

J W Proksch1, W B Gentry, S M Owens.   

Abstract

The goal of these studies was to examine the relationship between the rate of phencyclidine (PCP) administration and PCP tissue distribution. The time course of PCP distribution in serum, brain, and testis after rapid (i.v.) and slow (s.c.) administration was studied. Brain and serum PCP concentrations after an i.v. bolus dose (1 mg/kg at 900 microg/min) were highest at 30 s and decreased biphasically, with serum concentrations decreasing 30 times faster than brain concentrations during the early phase. Consequently, the brain-to-serum PCP concentration ratio increased from 8:1 at 30 s to 14:1 at 20 min before equilibrating at a ratio of 3:1 that remained constant from 1 to 8 h. In contrast, the testis-to-serum ratio increased slowly from 1:1 to 12:1 over 4 h, and then remained constant. In a separate group of animals, an s.c. infusion of PCP (18 mg/kg/day or 3.6 microg/min) produced a brain-to-serum ratio (6:1) that remained constant throughout the 96-h infusion. Testis-to-serum ratios increased from 4:1 at 1 h to 12:1 at 8 h and then remained constant for 96 h. Steady-state infusion of a pharmacologically inactive dose (2.5 mg/kg/day) produced a brain-to-serum ratio (3:1) that was significantly lower than the ratio (6:1) after infusion of the three pharmacologically active doses (10-25 mg/kg/day). The temporary high brain PCP concentrations and the dynamic disequilibrium between brain and serum concentrations after rapid i.v. administration could provide a better understanding of the preference of the human drug abuser for rapid rates (e.g., i.v. or smoking) of drug administration.

Entities:  

Mesh:

Substances:

Year:  2000        PMID: 10859146

Source DB:  PubMed          Journal:  Drug Metab Dispos        ISSN: 0090-9556            Impact factor:   3.922


  10 in total

1.  Chronic anti-phencyclidine monoclonal antibody therapy decreases phencyclidine-induced in utero fetal mortality in pregnant rats.

Authors:  J J Hubbard; E M Laurenzana; D K Williams; W B Gentry; S M Owens
Journal:  Int Immunopharmacol       Date:  2011-10-12       Impact factor: 4.932

2.  The pharmacokinetics of racemic MDPV and its (R) and (S) enantiomers in female and male rats.

Authors:  Michael D Hambuchen; Howard P Hendrickson; Melinda G Gunnell; Samantha J McClenahan; Laura E Ewing; Dillon M Gibson; Michael D Berquist; S Michael Owens
Journal:  Drug Alcohol Depend       Date:  2017-08-08       Impact factor: 4.492

3.  Antagonism at serotonin 5-HT(2A) receptors modulates functional activity of frontohippocampal circuit.

Authors:  Alessandro Gozzi; Valerio Crestan; Giuliano Turrini; Marcel Clemens; Angelo Bifone
Journal:  Psychopharmacology (Berl)       Date:  2010-01-29       Impact factor: 4.530

Review 4.  Monoclonal antibodies as pharmacokinetic antagonists for the treatment of (+)-methamphetamine addiction.

Authors:  S Michael Owens; William T Atchley; Michael D Hambuchen; Eric C Peterson; W Brooks Gentry
Journal:  CNS Neurol Disord Drug Targets       Date:  2011-12       Impact factor: 4.388

5.  Engineering and characterization of a mouse/human chimeric anti-phencyclidine monoclonal antibody.

Authors:  H Marie Lacy; Melinda G Gunnell; Elizabeth M Laurenzana; S Michael Owens
Journal:  Int Immunopharmacol       Date:  2007-10-23       Impact factor: 4.932

6.  Acute Phencyclidine Alters Neural Oscillations Evoked by Tones in the Auditory Cortex of Rats.

Authors:  Ashley M Schnakenberg Martin; Brian F OʼDonnell; James B Millward; Jenifer L Vohs; Emma Leishman; Amanda R Bolbecker; Olga Rass; Sandra L Morzorati
Journal:  Neuropsychobiology       Date:  2017-10-24       Impact factor: 2.328

7.  Vulnerability to (+)-methamphetamine effects and the relationship to drug disposition in pregnant rats during chronic infusion.

Authors:  Sarah J White; Elizabeth M Laurenzana; William Brooks Gentry; Howard P Hendrickson; David Keith Williams; Keith W Ward; Samuel Michael Owens
Journal:  Toxicol Sci       Date:  2009-06-10       Impact factor: 4.849

8.  Inhibition of g protein-activated inwardly rectifying k channels by phencyclidine.

Authors:  Toru Kobayashi; Daisuke Nishizawa; Kazutaka Ikeda
Journal:  Curr Neuropharmacol       Date:  2011-03       Impact factor: 7.363

9.  In Vitro and In Vivo Sequestration of Phencyclidine by Me4 Cucurbit[8]uril*.

Authors:  Steven Murkli; Jared Klemm; Adam T Brockett; Michael Shuster; Volker Briken; Matthew R Roesch; Lyle Isaacs
Journal:  Chemistry       Date:  2021-01-19       Impact factor: 5.236

10.  Phencyclidine Disrupts the Auditory Steady State Response in Rats.

Authors:  Emma Leishman; Brian F O'Donnell; James B Millward; Jenifer L Vohs; Olga Rass; Giri P Krishnan; Amanda R Bolbecker; Sandra L Morzorati
Journal:  PLoS One       Date:  2015-08-10       Impact factor: 3.240

  10 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.